Pharmetheus offers consulting services focused on the application of pharmacometric approaches to support drug development decisions. The company was founded in 2012 in Uppsala, Sweden, as a spin-off to the Pharmacometrics Research Group at Uppsala University.
Pharmetheus consultants have wide experience in the area of Model Based Drug Development (MBDD) and are committed to performing efficient, high quality analyses in compliance with regulatory demands. The team of consultants and advisors is dedicated to developing fit-for-purpose models and analyses to answer the research questions of our clients.
Read more at www.pharmetheus.com